Physician profile
Max Cheng
NPI 1679249320
$5,124.39
in general payments reported to CMS, 2019-2025
19 companies · $1,753 in 2025
The $1,753 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $483 · 2022: $1,506 · 2023: $948 · 2024: $435 · 2025: $1,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,135.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,127.38 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $910.72 | 2022-2025 | Ozempic, Rybelsus, Tresiba |
| Xeris Pharmaceuticals, INC. | $450.68 | 2021-2025 | Gvoke Hypopen |
| Cequr Corporation | $421.30 | 2024-2025 | Cequr Simplicity |
| Insulet Corporation | $249.19 | 2021-2022 | |
| Corcept Therapeutics | $239.99 | 2024-2025 | Korlym |
| Horizon Therapeutics Plc | $220.21 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $217.19 | 2021-2023 | Jardiance |
| Dexcom, INC. | $215.36 | 2022-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $193.34 | 2022-2025 | Mounjaro |
| Jazz Pharmaceuticals INC. | $130.03 | 2021 | |
| Amgen INC. | $125.00 | 2025 | Tepezza |
| Bayer Healthcare Pharmaceuticals INC. | $124.88 | 2023 | |
| Neurocrine Biosciences, INC. | $103.81 | 2022 | |
| Ibsa Pharma INC. | $103.43 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.88 | 2022 | |
| Beta Bionics, INC. | $84.22 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Genzyme Corporation | $67.08 | 2022 | |
| Sanofi-Aventis U.S. LLC | $39.70 | 2023-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.